AHL Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$8.7M Sell
274,065
-152,978
-36% -$4.74M 0.14% 265
2017
Q3
$12.3M Buy
427,043
+122,653
+40% +$3.49M 0.22% 97
2017
Q2
$8.47M Buy
304,390
+58,643
+24% +$1.52M 0.18% 146
2017
Q1
$6.08M Buy
245,747
+170,601
+227% +$4.16M 0.13% 271
2016
Q4
$1.83M Sell
75,146
-221,279
-75% -$5.27M 0.06% 532
2016
Q3
$7.1M Buy
296,425
+221,178
+294% +$5.48M 0.26% 76
2016
Q2
$2.02M Buy
75,247
+51,590
+218% +$1.42M 0.11% 242
2016
Q1
$643K Sell
23,657
-185,766
-89% -$4.71M 0.04% 512
2015
Q4
$5.23M Buy
209,423
+172,057
+460% +$4.26M 0.4% 61
2015
Q3
$882K Sell
37,366
-165,642
-82% -$3.72M 0.14% 229
2015
Q2
$4.33M Buy
203,008
+88,451
+77% +$1.98M 0.17% 250
2015
Q1
$2.66M Sell
114,557
-3,609
-3% -$77.7K 0.11% 449
2014
Q4
$2.24M Buy
118,166
+100,914
+585% +$1.78M 0.12% 407
2014
Q3
$282K Buy
+17,252
New +$302K 0.02% 606

Other funds holding G

AHL Partners's G Position: Q4 2017 in Review

AHL Partners reduced its Genpact (G) stake by 36% in Q4 2017, selling an estimated $4.74M and leaving 274,065 shares worth $8.7M. The position accounts for 0.14% of the portfolio, ranked #265.

AHL Partners first reported a position in G in Q3 2014 and has held it in 14 quarters since. The position peaked at $12.3M in Q3 2017. 241 funds tracked by Wall St. Rank hold G as of Q4 2017.

  • AHL Partners held 274,065 shares of Genpact worth $8.7M as of Q4 2017.
  • AHL Partners sold 152,978 Genpact shares in Q4 2017, an estimated $4.74M.
  • Genpact made up 0.14% of AHL Partners's portfolio in Q4 2017, its #265 holding.
  • AHL Partners first reported a position in Genpact in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Genpact position peaked at $12.3M in Q3 2017.
  • 241 funds tracked by Wall St. Rank held Genpact as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.